Form D · Biotechnology

Knopp Neurosciences Inc.

Pittsburgh, PA · CIK 0001347819

Offering snapshot reported Sep 3, 2010 · SEC filing

Reported sold
$60M
Offering amount: $60M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 23, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 3, 2010Initial$60,000,000No comparison1SEC filing
Jan 13, 2010Amendment$8,500,001No comparison26SEC filing
Dec 23, 2009Amendment$4,423,875No comparison26SEC filing
Sep 23, 2009Initial$23,257No comparison2SEC filing
Dec 19, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 12, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Dec 21, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-147281

Source: Form D, filed Sep 3, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael E. Bozik Director, Executive, Promoter
Benjamin A. Gomez Director
Ben Gomez Director
Valentin K. Gribkoff Executive
Gregory T. Hebrank Director, Executive, Promoter
Evan Ingersoll Executive
Jeffrey S. Mc Cormick Director
Thomas, Jr. Petzinger Director, Executive, Promoter
Thomas Petzinger, Jr. Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2100 Wharton Street Suite 615
Pittsburgh, PA, 15203